Cystatin C Assay Market Poised to Reach Over US$ 1.2 Billion by 2034, Driven by Advances in Renal Diagnostics | Transparency Market Research [Yahoo! Finance]
SIEMENS AG SPONS ADR (SIEGY)
NASDAQ:AMEX Investor Relations:
siemens.com/investor
Company Research
Source: Yahoo! Finance
With chronic kidney disease (CKD) becoming a critical global health issue, the market is projected to grow at a robust CAGR of 6.6% from 2024 to 2034, doubling its value to surpass US$ 1.2 billion by the end of the forecast period. Wilmington, Delaware, United States – Transparency Market Research Inc, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Global cystatin C assay market (marché du dosage de la cystatine C), valued at US$ 0.6 billion in 2023, is driven by advancements in renal diagnostics and increasing awareness of chronic kidney disease. Early and precise renal function monitoring is at the forefront of modern healthcare strategies, significantly boosting the demand for cystatin C assays . The market is expected to grow at a CAGR of 6.6% from 2024 to 2034, with projections indicating the market will exceed US$ 1.2 billion by the end of the forecast period. Cystatin C, a biomarker of kidney function, provides more reliable and earlier detection of renal impairment compared to traditio
Show less
Read more
Impact Snapshot
Event Time:
SIEGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIEGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIEGY alerts
High impacting SIEMENS AG SPONS ADR news events
Weekly update
A roundup of the hottest topics
SIEGY
News
- Isaac Ullatil Joins Wellstack Board of Directors [Yahoo! Finance]Yahoo! Finance
- Siemens Aktiengesellschaft (OTCMKTS: SIEGY) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.MarketBeat
- ECHOLIGHT ANNOUNCES MULTI-YEAR AGREEMENT WITH SIEMENS HEALTHINEERS [Yahoo! Finance]Yahoo! Finance
- Optomec and Siemens Deliver Next Generation Manufacturing Solution for High Value Metal Repair [Yahoo! Finance]Yahoo! Finance
- Siemens AG (SIEGY) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Dividend Increase ... [Yahoo! Finance]Yahoo! Finance
SIEGY
Analyst Actions
- 10/5/24 - Citigroup Inc.
SIEGY
Sec Filings
- 11/14/24 - Form 13F-HR
- 8/30/24 - Form N-PX
- SIEGY's page on the SEC website